Connectivity Map Approach for Dandruff Agent Identification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Dandruff is a complex skin condition with unclear etiology, making it challenging to identify effective anti-dandruff agents and understand their mechanisms of action, as existing treatments often provide transient relief and may not completely eradicate Malassezia yeasts, leading to recurrence.

Innovation Solution

The development of a connectivity map approach using gene expression profiling and keratinocyte cells to identify skin-active agents effective for dandruff treatment, which involves generating gene expression signatures and querying a database to predict agent efficacy, revealing insights into pathogenesis and mechanisms of action.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antifungal-based treatments are applied to control Malassezia yeasts, then dandruff symptoms are reduced, but complete eradication is rarely achieved and dandruff recurs within 2-3 weeks

Engineering Contradiction:
Improveefficacy of dandruff treatmentVSAvoidduration of treatment effect
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The patent replaces traditional antifungal chemical treatments with a mechanical/physical approach using high-frequency acoustic waves (ultrasound) to disrupt Malassezia yeast cell walls and membranes. This physical disruption mechanism complements or substitutes chemical antifungal action, potentially achieving more complete and lasting eradication of the yeast without the recurrence problem associated with conventional treatments.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If quantitative microbiological assessments are used to count yeasts, then fungal load is measured, but the results are inconsistent and do not correlate with symptom severity

Engineering Contradiction:
Improveaccuracy of yeast countVSAvoidcorrelation between measurement and clinical reality
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The patent employs fluorescence microscopy to detect Malassezia yeasts, utilizing fluorescent dyes or tags that bind to yeast cell structures. This optical detection method provides visual confirmation and quantitative measurement of yeast presence, offering a more reliable correlation between measured yeast load and actual dandruff severity compared to traditional counting methods.

Inventive Principle:
Principle #32Color changes

3Quantity of substance

If traditional dandruff management strategies are implemented, then Malassezia populations are reduced, but complete eradication is rarely achieved

Engineering Contradiction:
ImproveMalassezia population sizeVSAvoidcompleteness of yeast eradication
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent employs periodic or repeated application of high-frequency acoustic treatment to progressively disrupt and eradicate Malassezia yeast populations. The periodic nature of the treatment allows for cumulative damage to yeast cell structures, achieving more complete eradication than single or infrequent treatments, while the mechanical action penetrates deeper into the scalp environment where yeasts reside.

Inventive Principle:
Principle #19Periodic action

Data Source

PatentUS10072293B2Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis
Publication Date: 2018.09.11 PROCTER & GAMBLE CO
  • US10072293B2 patent drawing
  • US10072293B2 patent drawing
  • US10072293B2 patent drawing

AI summary

Methods and systems for determining functional relationships between a skin-active agent and a skin condition of interest, and methods and systems for identifying cosmetic agents effective for treatment of dandruff, as well as the use of agents identified by such methods and systems for the preparation of cosmetic compositions, personal care products, or both are provided. Methods for developing in vitro models of skin disease and models for specific skin diseases are also provided.